Rotating injection sites each week will help
When GLP-1 receptor agonists are used alongside insulin, sulfonylureas (such as gliclazide), or meglitinides, there is an increased risk of hypoglycaemia
Sources Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies Diabetes, Obesity and Metabolism, Neeland et al., 2024 Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss
Jacob, a 52-year-old small business owner, has struggled to adapt to his new reality, facing financial and emotional challenges as he navigates the complexities of life with a severe visual impairment
After years of receiving haircuts in a familiar environment from his brother Jake, he decided he was ready to take that next step, and his local Great Clips salon was ready to give him a great experience